Fed. Circ. Judge Asks What's The Rush In Eylea Biosimilar Case

By Nadia Dreid · January 14, 2025, 9:34 PM EST

Counsel for Amgen and a Federal Circuit judge got into a back-and-forth Tuesday concerning the pace of an appeal over a denied injunction on Regeneron's biosimilar of Eylea, with the judge...

To view the full article, register now.

Case Information

Case Title

Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.

Case Number

24-2351

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Qst.)

Date Filed

September 24, 2024